# A Metagenomics Approach to Frailty in Patients With Cirrhosis Undergoing a Multifactorial Intervention

**Authors:** Sara Vega‐Abellaneda, Eva Román, Zaida Soler, Mª. Àngels Ortiz, Giacomo Rossi, Lucia Biagini, Elisabet Sánchez, Marc Pons‐Tarin, Luca Laghi, Carlo Mengucci, Naujot Kaur, Maria Poca, Berta Cuyàs, Gerard Serrano‐Gomez, Edilmar Alvarado, Chaysavanh Manichanh, German Soriano

PMC · DOI: 10.1111/liv.70418 · Liver International · 2025-11-01

## TL;DR

This study explores how gut microbiota relates to frailty in cirrhosis patients and finds that a 12-month intervention improves frailty alongside changes in the microbiome.

## Contribution

The study is the first to link frailty with gut microbiota in cirrhosis patients and shows that a multifactorial intervention can alter the microbiome and improve frailty.

## Key findings

- Frailty in cirrhosis patients is associated with specific gut microbiota signatures.
- A 12-month intervention improved frailty and altered microbiota composition, including increased Bifidobacterium and Lactobacillus species.
- Rothia dentocariosa and Bacteroides faecis were positively correlated with frailty measures like LFI and gait speed.

## Abstract

The relationship between frailty and gut microbiota has not been previously addressed in patients with cirrhosis. We studied by metagenomic shotgun sequencing the faecal microbiota composition associated with frailty in 29 patients with cirrhosis from a previous study (Román, Hepatol Commun 2024). Frail and prefrail patients were randomised to a multifactorial intervention (home exercise, branched‐chain amino acids and a multistrain probiotic) or control for 12 months. We observed a positive correlation between the abundance of 
Rothia dentocariosa
 and the Liver frailty index (LFI), and between 
Bacteroides faecis
 and gait speed. After the multifactorial intervention, LFI improved and the main changes in the microbiota composition were a decrease in the abundance of 
Akkermansia muciniphila
, and an increase in 
Streptococcus thermophilus
, 
Lactobacillus acidophilus
 and several species of Bifidobacterium. We conclude that frailty in patients with cirrhosis was associated with a distinct microbiome signature. After a long‐term multifactorial intervention, frailty improved in parallel with changes in microbiome composition.

Trial Registration:
ClinicalTrials.gov identifier: NCT04243148.

## Linked entities

- **Diseases:** cirrhosis (MONDO:0005155)
- **Species:** Rothia dentocariosa (taxon 2047), Bacteroides faecis (taxon 674529), Akkermansia muciniphila (taxon 239935), Streptococcus thermophilus (taxon 1308), Lactobacillus acidophilus (taxon 1579), Bifidobacterium (taxon 1678)

## Full-text entities

- **Diseases:** Frailty (MESH:D000073496), Cirrhosis (MESH:D005355)
- **Chemicals:** branched-chain amino acids (MESH:D000597)
- **Species:** Akkermansia muciniphila (species) [taxon 239935], Lactobacillus acidophilus (species) [taxon 1579], Streptococcus thermophilus (species) [taxon 1308], Bifidobacterium (genus) [taxon 1678], Bacteroides faecis (species) [taxon 674529], Rothia dentocariosa (species) [taxon 2047], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12579327/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12579327/full.md

## References

20 references — full list in the complete paper: https://tomesphere.com/paper/PMC12579327/full.md

---
Source: https://tomesphere.com/paper/PMC12579327